Teladoc Health, Inc. TDOC
As ofNov 20, 2026, 3:19 PM EST
- YTD
- +8.14%
- 1 year
- +11.98%
5D -0.87 (-10.05%)
- Market cap
- 1.38B
- Revenue (ttm)
- 2.47B
- Profit margin
- -6.27%
- EPS (ttm)
- -0.86
- Shares out
- 182.29M
- Forward P/E
- -14.08
- YTD return
- +8.14%
- 1-year return
- +11.98%
- 50-day average
- 6.89
- 200-day average
- 6.66
- Volume
- 2.96M
- Avg volume
- 4.22M
- Open
- 7.68
- Previous close
- 7.79
- Day's range
- 7.40 – 7.88
- 52-week range
- 4.40 – 9.89
- Beta
- 1.97
- Analysts
- Hold
- Price target
- 8.86 (+17.1%)
- Earnings date
- Feb 24, 2027
Key statistics
- Enterprise value
- 1.65B
- Price / sales
- 0.58
- Price / book
- 1.10
- Revenue growth
- -3.40%
- Free cash flow
- 195.67M
- Total cash
- 849.91M
- Total debt
- 1.04B
- Return on equity
- -11.52%
- Short % of float
- 17.74%
Fundamental scorecard
8 of 25 checks passed on TDOC’s reported financials
8of 25 checks passed
- Value 2 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: hold
- Target (low)
- 6.00
- Target (mean)
- 8.86
- Target (high)
- 11.50
- Strong buy1
- Buy5
- Hold16
- Sell1
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate -0.095.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | -0.11 | — | — | — |
| Oct 28, 2026 | Sep 30, 2026 | -0.21727 | -0.15 | +0.07 | +30.96% |
| Jul 29, 2026 | Jun 30, 2026 | -0.24975 | -0.21 | +0.04 | +15.92% |
| Apr 29, 2026 | Mar 31, 2026 | -0.34116 | -0.36 | -0.02 | -5.52% |
| Feb 25, 2026 | Dec 31, 2025 | -0.19 | -0.14 | +0.05 | +26.32% |
| Oct 29, 2025 | Sep 30, 2025 | -0.26 | -0.28 | -0.02 | -7.69% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2026 | Truist Securities | main | Hold | Hold |
| Nov 9, 2026 | TD Cowen | main | Hold | Hold |
| Nov 5, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Nov 4, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | UBS | main | Neutral | Neutral |
| Nov 2, 2026 | Oppenheimer | main | Outperform | Outperform |
About Teladoc Health, Inc.
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- teladochealth.com
News
Truist Securities Maintains Hold on Teladoc Health, Raises Price Target to $9
Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications TD Cowen Maintains Hold on Teladoc Health, Raises Price Target to $8
Wells Fargo Maintains Equal-Weight on Teladoc Health, Raises Price Target to $8
Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9
UBS Maintains Neutral on Teladoc Health, Raises Price Target to $9
Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10
JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10
Crude Oil Moves Lower; Caterpillar Shares Fall Following Q3 Results
12 Health Care Stocks Moving In Thursday's Intraday Session
Your note
Sign in to keep a note on TDOC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLISS KELLY | Officer | Sale | Sep 1, 2026 | 92,832 |
| CATAPANO JOSEPH RONALD | Officer | Sale | Oct 1, 2026 | 14,293 |
| DIVITA CHARLESIII | Chief Executive Officer | Sale | Sep 10, 2026 | 465,535 |
| JACOBSON CATHERINE | Director | Conversion of Exercise of derivative security | May 19, 2026 | 66,853 |
| MCKINLEY THOMAS G | Director | Conversion of Exercise of derivative security | May 20, 2025 | 56,544 |
| MURTHY MALA | Chief Financial Officer | Sale | Sep 1, 2025 | 142,385 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.28% | 18,734,280 | 146.13M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 7.83% | 14,265,590 | 111.27M | Sep 29, 2026 |
| American Century Companies Inc | 5.22% | 9,511,923 | 74.19M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 4.99% | 9,100,047 | 70.98M | Sep 29, 2026 |
| Voss Capital, LP | 4.84% | 8,825,000 | 68.84M | Sep 29, 2026 |
| Renaissance Technologies, LLC | 4.39% | 8,002,842 | 62.42M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 4.32% | 7,877,823 | 61.45M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.12% | 5,687,282 | 44.36M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.58% | 4,710,197 | 36.74M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.27% | 4,143,156 | 32.32M | Jun 29, 2026 |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 1.65% | 3,012,372 | 23.50M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.44% | 2,622,420 | 20.46M | Jun 29, 2026 |
